Skip to main content

Table 2 Risk factors associated with SARS-CoV-2 infection among PLWH and HIV-negative people (N = 2,254)

From: Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China

 

aOR (95%CI)

p value

Sex

 Male (ref)

  Female

1.39 (1.05–1.83)

0.019

  Age, years

0.98 (0.97–0.99)

0.005

  HIV infection

0.56 (0.42–0.75)

 < 0.001

COVID-19 vaccination

 One dose/two doses (ref)

  Three doses

1.02 (0.75–1.38)

0.879

  Four dosesa

0.18 (0.11–0.28)

 < 0.001

  Unvaccinated

0.65 (0.40–1.06)

0.089

  Diabetes

0.86 (0.45–1.65)

0.662

  Cardiovascular and cerebrovascular diseases

0.92 (0.58–1.46)

0.745

  Chronic lung diseases

1.09 (0.52–2.28)

0.811

  Chronic kidney diseases

0.51 (0.21–1.23)

0.137

  Chronic liver Diseases

0.78 (0.41–1.46)

0.443

  1. arefers to three doses of inactivated COVID-19 vaccines plus one dose of inhaled recombinant adenovirus type 5 (AD5)-vectored COVID-19 vaccine, Convidecia